Sorrento Therapeutics Cuts Ties With Chief Financial Officer Jiong Shao

Xconomy San Diego — 

Sorrento Therapeutics (NASDAQ: SRNE) has fired its chief financial officer, Jiong Shao, according to a regulatory filing.

The San Diego-based company, which is among the biotechs developing potential COVID-19 treatments and tests, didn’t explain why. Sorrento appointed Najjam Asghar, its chief accounting officer, to handle CFO responsibilities as well until the firm finds a successor. Before joining Sorrento in June 2019, Asghar held various roles at medical device company NuVasive (NASDAQ: NUVA). Prior he worked at accounting firm PricewaterhouseCoopers.